Literature DB >> 31374239

Preparation, physicochemical properties, in vitro evaluation and release behavior of cephalexin-loaded niosomes.

Robabehbeygom Ghafelehbashi1, Iman Akbarzadeh2, Mohammad Tavakkoli Yaraki3, Aseman Lajevardi4, Mahdi Fatemizadeh5, Leily Heidarpoor Saremi6.   

Abstract

In this study, optimized cephalexin-loaded niosomal formulations based on span 60 and tween 60 were prepared as a promising drug carrier system. The niosomal formulations were characterized using a series of techniques such as scanning electron microscopy, Fourier transformed infrared spectroscopy, dynamic light scattering, and zeta potential measurement. The size and drug encapsulation efficiency are determined by the type and composition of surfactant. The developed niosomal formulations showed great storage stability up to 30 days with low change in size and drug entrapment during the storage, making them potential candidates for real applications. Moreover, the prepared niosomes showed negligible cytotoxicity for HepG2 cells, measured by MTT assay. The antibacterial properties of cephalexin-loaded niosome were investigated using S. aureus and E. coli as gram-positive and gram-negative bacteria, respectively. The results showed that the encapsulation of antibiotic drug in niosomal formulation could enhance the antibacterial efficiency of the drug, where the minimum inhibitory concentration was droped from 8 µg/mL (cephalexin) to 4 µg/mL (cephalexin-loaded niosome) and from 4 µg/mL (cephalexin) to 1 µg/mL (cephalexin-loaded niosome) against E. coli and S. aureus, respectively. The findings of our study show that the improvement of cephalexin bioavailability and prolonged drug release profile could be obtained by niosomal formulation as a favorable antibiotic drug delivery system.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibacterial; Cephalexin; Cytotoxicity; Drug delivery; Niosome

Year:  2019        PMID: 31374239     DOI: 10.1016/j.ijpharm.2019.118580

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  18 in total

Review 1.  Recent advances in porphyrin-based nanocomposites for effective targeted imaging and therapy.

Authors:  Navid Rabiee; Mohammad Tavakkoli Yaraki; Soha Mokhtari Garakani; Shima Mokhtari Garakani; Sepideh Ahmadi; Aseman Lajevardi; Mojtaba Bagherzadeh; Mohammad Rabiee; Lobat Tayebi; Mohammadreza Tahriri; Michael R Hamblin
Journal:  Biomaterials       Date:  2019-12-18       Impact factor: 12.479

2.  Venlafaxine HCl Encapsulated in Niosome: Green and Eco-friendly Formulation for the Management of Pain.

Authors:  Seyyed Mohammad Hassan Hashemi; Reza Enayatifard; Jafar Akbari; Majid Saeedi; Mohammad Seyedabadi; Katayoun Morteza-Semnani; Amirhossein Babaei; Kofi Asare-Addo; Ali Nokhodchi
Journal:  AAPS PharmSciTech       Date:  2022-05-20       Impact factor: 3.246

3.  Preparation, characterization, and evaluation of eosin B-loaded nano-liposomes for growth inhibition of Plasmodium falciparum.

Authors:  Mana Najafzadeh; Haleh Bakhshandeh; Zahra Zamani; Monire Movahedi; Seyed Mohammad Atyabi
Journal:  Parasitol Res       Date:  2022-01-06       Impact factor: 2.289

Review 4.  Niosomes: a novel targeted drug delivery system for cancer.

Authors:  Maryam Moghtaderi; Kamand Sedaghatnia; Mahsa Bourbour; Mahdi Fatemizadeh; Zahra Salehi Moghaddam; Faranak Hejabi; Fatemeh Heidari; Sameer Quazi; Bahareh Farasati Far
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

5.  Synthesis and Characterization of Tetracycline Loaded Methionine-Coated NiFe2O4 Nanoparticles for Anticancer and Antibacterial Applications.

Authors:  Faten Eshrati Yeganeh; Amir Eshrati Yeganeh; Bahareh Farasati Far; Afsoun Mansouri; Belay Zeleke Sibuh; Saravanan Krishnan; Soumya Pandit; Walaa F Alsanie; Vijay Kumar Thakur; Piyush Kumar Gupta
Journal:  Nanomaterials (Basel)       Date:  2022-07-03       Impact factor: 5.719

6.  Assessment of the in vitro activity of azithromycin niosomes alone and in combination with levofloxacin on extensively drug-resistant Klebsiella pneumoniae clinical isolates.

Authors:  Hoda Mohamed Owais; Manal Mohammad Baddour; Hala Abd El-Raouf El-Metwally; Heba Soliman Barakat; Nour Sherif Ammar; Marwa Ahmed Meheissen
Journal:  Braz J Microbiol       Date:  2021-01-22       Impact factor: 2.476

7.  The Optimized Formulation of Tamoxifen-Loaded Niosomes Efficiently Induced Apoptosis and Cell Cycle Arrest in Breast Cancer Cells.

Authors:  Iman Akbarzadeh; Mahsa Farid; Mehrnoosh Javidfar; Negar Zabet; Bahare Shokoohian; Mandana Kazem Arki; Anastasia Shpichka; Hassan Noorbazargan; Hamid Asadzadeh Aghdaei; Nikoo Hossein-Khannazer; Peter Timashev; Pooyan Makvandi; Massoud Vosough
Journal:  AAPS PharmSciTech       Date:  2022-01-19       Impact factor: 3.246

8.  Enhanced Antibacterial Activity of Echinacea angustifolia Extract against Multidrug-Resistant Klebsiella pneumoniae through Niosome Encapsulation.

Authors:  Maryam Moghtaderi; Amir Mirzaie; Negar Zabet; Ali Moammeri; Amirreza Mansoori-Kermani; Iman Akbarzadeh; Faten Eshrati Yeganeh; Arman Chitgarzadeh; Aliasghar Bagheri Kashtali; Qun Ren
Journal:  Nanomaterials (Basel)       Date:  2021-06-15       Impact factor: 5.076

9.  Isoniazid Conjugated Magnetic Nanoparticles Loaded with Amphotericin B as a Potent Antiamoebic Agent against Acanthamoeba castellanii.

Authors:  Kawish Iqbal; Sumayah Abdelnasir Osman Abdalla; Ayaz Anwar; Kanwal Muhammad Iqbal; Muhammad Raza Shah; Areeba Anwar; Ruqaiyyah Siddiqui; Naveed Ahmed Khan
Journal:  Antibiotics (Basel)       Date:  2020-05-25

10.  Controllable Drug Delivery by Na+/K+ ATPase α1 Targeting Peptide Conjugated DSPE-PEG Nanocarriers for Breast Cancer.

Authors:  Yayan Yang; Qian Feng; Chuanfeng Ding; Wei Kang; Xiufeng Xiao; Yongsheng Yu; Qian Zhou
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.